Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2021 | 07-2021 | 06-2021 | 04-2021 | 03-2021 | |
| Operating Expenses | 3,584 | 2,306 | 1,390 | 1,221 | 0 |
| Operating Income | -3,584 | -2,306 | -1,390 | -1,221 | N/A |
| Interest Expense | 16 | 14 | 0 | 42 | 0 |
| Other Income | 0 | 0 | 0 | 6 | 0 |
| Pre-tax Income | -3,600 | -2,320 | -1,390 | -1,257 | 0 |
| Net Income Continuous | -3,600 | -2,320 | 0 | -1,257 | 0 |
| Net Income | $-3,600 | $-2,320 | $-2,320 | $-1,257 | $0 |
| EPS Basic Total Ops | -6.00 | -4.50 | N/A | -1.50 | N/A |
| EPS Basic Continuous Ops | -5.78 | -4.11 | N/A | -2.55 | N/A |
| EPS Diluted Total Ops | -6.00 | -4.50 | N/A | -1.50 | N/A |
| EPS Diluted Continuous Ops | -5.78 | -4.11 | N/A | -2.55 | N/A |
| EBITDA(a) | $-3,584 | $-2,306 | $-1,390 | $-1,221 | $N/A |